• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Itching Sensation (1943); Cognitive Changes (2551)
Event Date 05/11/2017
Event Type  Injury  
Manufacturer Narrative
Please note that this date is based off of the date that the article was accepted for publication as the event dates were not provided in the published literature.
 
Event Description
Mulders, aep., leentjens, afg., schruers, k., duits, a., ackermans, l., temel, y.Choreatic side-effects of deep brain stimulation of the anteromedial subthalamic nucleus for treatment-resistant obsessive-compulsive disorder: a case report.World neurosurg.2017.Doi: 10.1016/j.Wneu.2017.05.067 summary: background: patients with treatment-resistant obsessive-compulsive disorder (ocd) are potential candidates for deep brain stimulation (dbs).The anteromedial subthalamic nucleus (stn) is amongst the most commonly used targets for dbs in ocd.Case description: we present a patient with a 30-year history of treatment-resistant ocd who underwent anteromedial stn-dbs.Despite a clear mood-enhancing effect, stimulation caused motor side-effects including bilateral hyperkinesia, dyskinesias and sudden large amplitude choreatic movements of arms and legs when stimulating at voltages above circa 1.5v.Dbs at lower amplitudes and at other contact points failed to result in a significant reduction of obsessions and compulsions without inducing motor side-effects.Due to this limitation in programming options, we decided to re-operate and target the ventral capsule/ventral striatum (vc/vs), which resulted in a substantial reduction in key obsessive and compulsive symptoms without serious side-effects.Conclusion: choreatic movements and hemiballismus have previously been linked to stn dysfunction and have been incidentally reported as side-effect of dbs of the dorsolateral stn in parkinson's disease (pd).However, in pd, these side-effects were usually transient and rarely interfered with dbs programming.In our case, the motor side-effects were persistent and made optimal dbs programming impossible.To our knowledge such severe a nd persistent motor side effects have not yet been described for anteromedial stn-dbs.Reported events: a (b)(6) female patient who received bilateral deep brain stimulation (dbs) of the subthalamic nucleus (stn) for obsessive compulsive disorder (ocd) developed unexpected compulsive behavior towards their operation wounds, including scratching and itching, which the authors felt likely contributed to the development of a hardware infection.The infection was treated with removing the infected implantable neurostimulator (ins) and cables and antibiotic therapy.Two months later a new dbs was implanted and therapy reactivated.It was noted that the patient was implanted with 3389 model lead, but it was not possible to ascertain any further specific device information from the article or to match the reported event with any previously reported event.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6682636
MDR Text Key78900240
Report Number3007566237-2017-02619
Device Sequence Number1
Product Code MFR
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
H050003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/13/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-